Cargando…
Overexpression of CD151 Predicts Prognosis in Patients with Resected Gastric Cancer
PURPOSE: The tetraspanin CD151 acts as a promoter of metastasis and invasion in several tumors. However, the role of CD151 in human gastric cancer (HGC) remains unclear. METHODS: Twenty HGC specimens and matched nontumor samples, human gastric epithelial cells (HGEC), and four gastric cancer cell li...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3606477/ https://www.ncbi.nlm.nih.gov/pubmed/23533596 http://dx.doi.org/10.1371/journal.pone.0058990 |
_version_ | 1782264021122023424 |
---|---|
author | Yang, Yue-Ming Zhang, Zhong-Wei Liu, Qing-Meng Sun, Yi-Feng Yu, Ji-Ren Xu, Wei-Xing |
author_facet | Yang, Yue-Ming Zhang, Zhong-Wei Liu, Qing-Meng Sun, Yi-Feng Yu, Ji-Ren Xu, Wei-Xing |
author_sort | Yang, Yue-Ming |
collection | PubMed |
description | PURPOSE: The tetraspanin CD151 acts as a promoter of metastasis and invasion in several tumors. However, the role of CD151 in human gastric cancer (HGC) remains unclear. METHODS: Twenty HGC specimens and matched nontumor samples, human gastric epithelial cells (HGEC), and four gastric cancer cell lines were used to analyze CD151 expression. Short hairpin RNA-mediated downregulation of CD151 expression in HGC cells was performed to examine the role of CD151 in the proliferation and metastasis/invasion of HGC cells in vivo and in vitro. The relationship of CD151 with integrin α3 in HGC cells was investigated by silencing integrin α3 followed by co-immunoprecipitation and immunofluorescence staining. Finally, the prognostic value of CD151 and integrin α3 was evaluated by immunohistochemistry in tissue microarrays of 76 HGC patients. RESULTS: CD151 was expressed at higher levels in HGC tissues and HGC cells than in nontumor tissues and HGEC cells. Down-regulation of CD151 by vshRNA-CD151 impaired metastasis and invasion of HGC-27 cells, but did not affect cell proliferation. CD151 formed a complex with integrin α3 in HGC cells. CD151-cDNA transfection rescued the metastatic potential and invasiveness of HGC-27-vshCD151 cells, but not those of HGC-27-vshintegrin α3 cells in vitro. Clinically, CD151 overexpression was significantly correlated with high TNM stage, depth of invasion and positive lymph node involvement (p<0.05), and high levels of integrin α3 were associated with large tumor size, high TNM stage, depth of invasion and lymph node involvement (p<0.05). Importantly, the postoperative 5-year overall survival of patients with CD151(low) and/or integrin α3(low) was higher than that of patients with CD151(high) and/or integrin α3(high). CONCLUSION: CD151 is positively associated with the invasiveness of HGC, and CD151 or the combination of CD151 and integrin α3 is a novel marker for predicting the prognosis of HGC patients and may be potential therapeutic targets. |
format | Online Article Text |
id | pubmed-3606477 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-36064772013-03-26 Overexpression of CD151 Predicts Prognosis in Patients with Resected Gastric Cancer Yang, Yue-Ming Zhang, Zhong-Wei Liu, Qing-Meng Sun, Yi-Feng Yu, Ji-Ren Xu, Wei-Xing PLoS One Research Article PURPOSE: The tetraspanin CD151 acts as a promoter of metastasis and invasion in several tumors. However, the role of CD151 in human gastric cancer (HGC) remains unclear. METHODS: Twenty HGC specimens and matched nontumor samples, human gastric epithelial cells (HGEC), and four gastric cancer cell lines were used to analyze CD151 expression. Short hairpin RNA-mediated downregulation of CD151 expression in HGC cells was performed to examine the role of CD151 in the proliferation and metastasis/invasion of HGC cells in vivo and in vitro. The relationship of CD151 with integrin α3 in HGC cells was investigated by silencing integrin α3 followed by co-immunoprecipitation and immunofluorescence staining. Finally, the prognostic value of CD151 and integrin α3 was evaluated by immunohistochemistry in tissue microarrays of 76 HGC patients. RESULTS: CD151 was expressed at higher levels in HGC tissues and HGC cells than in nontumor tissues and HGEC cells. Down-regulation of CD151 by vshRNA-CD151 impaired metastasis and invasion of HGC-27 cells, but did not affect cell proliferation. CD151 formed a complex with integrin α3 in HGC cells. CD151-cDNA transfection rescued the metastatic potential and invasiveness of HGC-27-vshCD151 cells, but not those of HGC-27-vshintegrin α3 cells in vitro. Clinically, CD151 overexpression was significantly correlated with high TNM stage, depth of invasion and positive lymph node involvement (p<0.05), and high levels of integrin α3 were associated with large tumor size, high TNM stage, depth of invasion and lymph node involvement (p<0.05). Importantly, the postoperative 5-year overall survival of patients with CD151(low) and/or integrin α3(low) was higher than that of patients with CD151(high) and/or integrin α3(high). CONCLUSION: CD151 is positively associated with the invasiveness of HGC, and CD151 or the combination of CD151 and integrin α3 is a novel marker for predicting the prognosis of HGC patients and may be potential therapeutic targets. Public Library of Science 2013-03-22 /pmc/articles/PMC3606477/ /pubmed/23533596 http://dx.doi.org/10.1371/journal.pone.0058990 Text en © 2013 Yang et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited. |
spellingShingle | Research Article Yang, Yue-Ming Zhang, Zhong-Wei Liu, Qing-Meng Sun, Yi-Feng Yu, Ji-Ren Xu, Wei-Xing Overexpression of CD151 Predicts Prognosis in Patients with Resected Gastric Cancer |
title | Overexpression of CD151 Predicts Prognosis in Patients with Resected Gastric Cancer |
title_full | Overexpression of CD151 Predicts Prognosis in Patients with Resected Gastric Cancer |
title_fullStr | Overexpression of CD151 Predicts Prognosis in Patients with Resected Gastric Cancer |
title_full_unstemmed | Overexpression of CD151 Predicts Prognosis in Patients with Resected Gastric Cancer |
title_short | Overexpression of CD151 Predicts Prognosis in Patients with Resected Gastric Cancer |
title_sort | overexpression of cd151 predicts prognosis in patients with resected gastric cancer |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3606477/ https://www.ncbi.nlm.nih.gov/pubmed/23533596 http://dx.doi.org/10.1371/journal.pone.0058990 |
work_keys_str_mv | AT yangyueming overexpressionofcd151predictsprognosisinpatientswithresectedgastriccancer AT zhangzhongwei overexpressionofcd151predictsprognosisinpatientswithresectedgastriccancer AT liuqingmeng overexpressionofcd151predictsprognosisinpatientswithresectedgastriccancer AT sunyifeng overexpressionofcd151predictsprognosisinpatientswithresectedgastriccancer AT yujiren overexpressionofcd151predictsprognosisinpatientswithresectedgastriccancer AT xuweixing overexpressionofcd151predictsprognosisinpatientswithresectedgastriccancer |